The global anemia supplements market size is anticipated to reach USD 3.71 billion by 2033 and is projected to grow at a CAGR of 8.44% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growth is attributed to increasing awareness of iron deficiency and its related complications, particularly among women, children, and the elderly. Rising emphasis on preventive healthcare, expanding prenatal and pediatric supplementation programs, and growing consumer adoption of OTC nutritional products continue to support market expansion. Furthermore, advancements in iron formulations, including iron bisglycinate, carbonyl iron, and fortified liquid supplements, are enhancing absorption and gastrointestinal tolerance, driving product preference. Government-led anemia reduction initiatives, improving healthcare infrastructure in emerging economies, and the proliferation of e-commerce channels also contribute to steady market penetration. In addition, consumer shift toward clean-label, plant-based, and fortified functional nutrition solutions is fueling innovation and widening product accessibility globally.
Moreover, the growing demand for prenatal and pediatric iron supplements, driven by maternal health programs and a focus on child nutrition, is strengthening market traction. Rising government initiatives to reduce anemia in women and children, alongside increased parental awareness of developmental needs and micronutrient deficiencies, are accelerating adoption. Expanding product availability to include liquid, chewable, and gentle formulations further enhances compliance and widens the consumer reach.
A key restraint in the anemia supplements industry is the gastrointestinal side effects associated with conventional iron formulations, including constipation, nausea, and digestive discomfort, which often lead to poor patient compliance. In addition, limited awareness in low-income regions, availability of low-cost generic alternatives, and preference for dietary sources or fortified foods over supplements may hinder consistent adoption and slow market expansion.
Request a free sample copy or view report summary: Anemia Supplements Market Report
By product, the ferrous fumarate segment accounted for the largest market revenue share in 2024, driven by owing to its high bioavailability, cost-effectiveness, and widespread clinical use for treating iron deficiency anemia. Its proven efficacy, favorable tolerance profile, and broad availability across prescription and OTC formulations further supported segment dominance.
By application, the iron deficiency anemia (IDA) treatment segment accounted for the largest market revenue share in 2024. This is attributed to the high global burden of anemia, increased diagnosis rates, and rising clinical adoption of iron supplements as first-line therapy. Growing awareness programs and government-led anemia control initiatives further supported segment growth.
By form, the tablets led the market with the largest revenue share of 40.63% in 2024. This leadership stems from their convenience, longer shelf life, cost-effectiveness, and broad availability across prescription and over-the-counter channels, making them a preferred choice for both patients and healthcare providers.
By distribution channel, the brick-and-mortar segment accounted for the largest market revenue share in 2024, supported by strong consumer trust in physical pharmacies and retail stores, wider product accessibility, and pharmacist-guided purchasing. In addition, established healthcare retail networks and in-store promotional activities further strengthened segment dominance.
Asia Pacific dominated the market with the largest revenue share of 34.19% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period, driven by rising anemia prevalence, expanding healthcare access, and increasing adoption of dietary supplements across emerging economies. Strong government nutrition initiatives and growing consumer awareness further support the expansion of the regional market.
Grand View Research has segmented the global anemia supplements market based on the product, form, application, distribution channel, and region.
Anemia Supplements Product Outlook (Revenue, USD Million, 2021 - 2033)
Ferrous Fumarate
Ferrous Gluconate
Ferrous Sulfate
Iron Bisglycinate
Others
Anemia Supplements Form Outlook (Revenue, USD Million, 2021 - 2033)
Tablets
Capsules
Liquids
Others
Anemia Supplements Application Outlook (Revenue, USD Million, 2021 - 2033)
Iron Deficiency Anemia (IDA) Treatment
Pediatric Care
Prenatal Use
Sports Nutrition
Others
Anemia Supplements Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Brick And Mortar
Direct Selling
Chemists/Pharmacies
Health Food Shops
Hypermarkets
Supermarkets
E-commerce
Anemia Supplements Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Anemia Supplements Market
Vitabiotics
Nature Made
NovaFerrum
Floradix
Feosol
Ferro-Sequels
Vitron-C
Solgar
Pure Encapsulations
Garden of Life
"The quality of research they have done for us has been excellent..."